BONUS - Pressing Pause on the Johnson and Johnson Vaccine
Public Health On Call · Johns Hopkins Bloomberg School of Public Health
April 16, 202111m 51s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week, the FDA paused the use of Johnson & Johnson's COVID-19 vaccine because of reports of six women under 50 who developed a rare form of blood clots called cerebral venous sinus thrombosis. Today, Stephanie Desmon talks with Dr. Josh Sharfstein about what this means for vaccine rollouts, vaccine hesitancy, and what might happen next. This bonus episode has been lifted from yesterday's Facebook live which can be seen at www.facebook.com/JohnsHopkinsSPH/.